Nilocap 150mg Capsule
Marketer
MSN Laboratories
Salt Composition
Nilotinib (150mg)
Overview Nilocap 150mg Capsule
Chronic myeloid leukemia (CML) is treated with Nilocap 150mg capsules, particularly in patients unresponsive to or intolerant of alternative leukemia therapies. Administer this medication on an empty stomach, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your individual needs and may fluctuate. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits might not be apparent for several weeks or months; discontinue only under medical supervision. Common side effects include headache, nausea, abdominal pain, and rash. Severe diarrhea necessitates medical consultation or increased fluid intake. Nilocap 150mg capsules can lower blood cell counts (red and white), increasing infection risk. Regular blood tests monitoring blood cell levels, heart, liver, uric acid, blood sugar, and lipid profiles are essential. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of anti-infectives. Potential drug interactions exist; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is mandatory for both partners throughout treatment.
Primary Ingredients of Nilocap 150mg Capsule
No text provided to rephrase.
Uses of Nilocap 150mg Capsule
Chronic myelogenous leukemia, a type of blood malignancy
Major Benefits of Nilocap 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Consume Nilocap 150mg Capsules on an empty stomach.
Common Side effects of Nilocap 150mg Capsule:
- Headache
- Nausea
- Abdominal pain
- Rash
- Itching
- Hair loss
- Muscle pain
- Fatigue
How to use Nilocap 150mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Nilocap 150mg Capsules should be ingested on an empty stomach.
How Nilocap 150mg Capsule works:
Nilocap 150mg capsules are an anticancer agent. Their mechanism involves inhibiting the activity of a faulty protein responsible for triggering cancer cell proliferation, thus curbing or retarding cancer progression.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Nilocap 150mg capsules presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Use of Nilocap 150mg capsules is contraindicated during pregnancy due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Breastfeeding mothers should avoid Nilocap 150mg Capsules. Evidence indicates potential infant harm from this medication.
DrivingUNSAFE
Taking a 150mg Nilocap capsule might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Nilocap 150mg capsules appear to pose minimal risk for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should exercise caution when using Nilocap 150mg capsules. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Nilocap 150mg Capsule :
Omit any missed Nilocap 150mg Capsule dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Nilocap 150mg Capsule
| Label | Value |
|---|---|
| Chemical Category | Pyrimidine-amine derivative |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently